Study hints at new target to improve immune therapy in triple-negative breast cancer

(University of Colorado Anschutz Medical Campus) University of Colorado Cancer Center study shows that Eya3 may regulate the immune response to a tumor, implying that anti-Eya3 therapies may improve checkpoint inhibitors against triple-negative breast cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news